Table 1 Preoperative patients’ and tumor characteristics.
Variable | L-RRRTM | C-RRRTM | p value |
|---|---|---|---|
N = 89 | N = 61 | ||
Age (median, range) yrs | 27 (16–66) | 28 (16–64) | 0.11 |
Histology compounds testis tumor; n (%) | |||
Seminoma | 28 (32) | 13 (21) | 0.29 |
Immature teratoma | 31 (35) | 11 (18) | 0.07 |
Mature teratoma | 46 (52) | 28 (46) | 0.69 |
Embryonal cell carcinoma | 73 (82) | 26 (43) | <0.001 |
Chorioncarcinoma | 6 (7) | 8 (13) | 0.11 |
Yolk sac | 41 (46) | 17 (28) | 0.05 |
IGCCCG risk score before chemotherapy; n (%) | |||
Good | 72 (81) | 18 (29) | <0.001 |
Intermediate | 12 (13) | 26 (43) | |
Poor | 5 (6) | 17 (28) | |
Stage (Royal Marsden); n% | |||
IIA | 15 (17) | 1 (2) | <0.05 |
IIB | 41 (46) | 11 (18) | |
IIC | 12 (14) | 19 (31) | |
III | 2 (2) | 13 (21) | |
IV | 19 (21) | 17 (28) | |
Residual tumor location; n (%) | |||
Para-aortic | 61 (69) | 25 (41) | 0.001 |
Paracaval | 9 (10) | 11 (18) | |
Inter-aorto/caval | 16 (18) | 21 (34) | |
Iliacal | 3 (3) | 4 (7) | |
Diameter RRTM mm (median range) | 20 (5–70) | 42 (11–220) | <0.001 |
